- Home
- AGAE vs VNRX Comparison
AGAE vs VNRX Comparison
Compare AGAE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGAE
- VNRX
- Stock Information
- Founded
- AGAE 2017
- VNRX N/A
- Country
- AGAE United States
- VNRX United States
- Employees
- AGAE N/A
- VNRX N/A
- Industry
- AGAE Cable & Other Pay Television Services
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AGAE Telecommunications
- VNRX Health Care
- Exchange
- AGAE Nasdaq
- VNRX Nasdaq
- Market Cap
- AGAE 47.2M
- VNRX 58.6M
- IPO Year
- AGAE N/A
- VNRX N/A
- Fundamental
- Price
- AGAE $1.12
- VNRX $0.58
- Analyst Decision
- AGAE
- VNRX Strong Buy
- Analyst Count
- AGAE 0
- VNRX 4
- Target Price
- AGAE N/A
- VNRX $4.17
- AVG Volume (30 Days)
- AGAE 21.9K
- VNRX 111.6K
- Earning Date
- AGAE 03-26-2025
- VNRX 05-12-2025
- Dividend Yield
- AGAE N/A
- VNRX N/A
- EPS Growth
- AGAE N/A
- VNRX N/A
- EPS
- AGAE N/A
- VNRX N/A
- Revenue
- AGAE $9,256,023.00
- VNRX $1,285,827.00
- Revenue This Year
- AGAE N/A
- VNRX $71,446.31
- Revenue Next Year
- AGAE N/A
- VNRX N/A
- P/E Ratio
- AGAE N/A
- VNRX N/A
- Revenue Growth
- AGAE 36.15
- VNRX 97.50
- 52 Week Low
- AGAE $0.61
- VNRX $0.43
- 52 Week High
- AGAE $1.57
- VNRX $1.02
- Technical
- Relative Strength Index (RSI)
- AGAE 61.30
- VNRX 47.15
- Support Level
- AGAE $1.00
- VNRX $0.55
- Resistance Level
- AGAE $1.10
- VNRX $0.65
- Average True Range (ATR)
- AGAE 0.06
- VNRX 0.04
- MACD
- AGAE 0.00
- VNRX -0.00
- Stochastic Oscillator
- AGAE 82.95
- VNRX 32.00
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.